Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TOP1 | P11387 | 5/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 3/20 | 0.32 |
| ▸ | AKT2 | P31751 | 3/20 | 0.32 |
| ▸ | AKT3 | Q9Y243 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709385 | 0.89 | TOP1 (0.40) | TOP1KDM4EALDH1A1LMNAMAPT | |
| SCHEMBL30709495 | 0.89 | KMT2A (0.42) | MEN1RAB9AKMT2AMAPK14KDM4E | |
| SCHEMBL30709517 | 0.87 | TOP1 (0.38) | MEN1KMT2ATOP1ALDH1A1LMNA | |
| SCHEMBL22148529 | 0.87 | TOP1 (0.40) | MEN1KMT2ATOP1KDM4EALDH1A1 | |
| SCHEMBL30709477 | 0.84 | PIK3CA (0.33) | MEN1KMT2ATOP1KDM4EALDH1A1 | |
| SCHEMBL30709371 | 0.84 | NPY5R (0.36) | RAB9ATOP1MAPK14KDM4EALDH1A1 | |
| SCHEMBL30709352 | 0.83 | TNF (0.39) | MEN1RAB9AKMT2AMAPK14 | |
| SCHEMBL30709653 | 0.83 | TNF (0.36) | MEN1RAB9AKMT2AMAPK14 | |
| SCHEMBL21562840 | 0.82 | KMT2A (0.35) | MEN1KMT2ATOP1MAPK14KDM4E | |
| SCHEMBL30709686 | 0.82 | MAPK14 (0.40) | MEN1RAB9AKMT2AMAPK14KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | MEN1 2193/4885RAB9A 3239/4885KMT2A 4367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.